Idiopathic Pulmonary Fibrosis: A Composite Physiologic Index Derived from Disease Extent Observed by Computed Tomography
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
In idiopathic pulmonary fibrosis, the quantitation of disease severity using pulmonary function tests is often confounded by emphysema. We have identified the composite physiologic index (CPI) most closely reflecting the morphologic extent of pulmonary fibrosis. Consecutive patients with a clinical/computed tomography (CT) diagnosis of idiopathic pulmonary fibrosis (n = 212) were divided into group I (n = 106) and group II (n = 106). The CPI was derived in group I (by fitting pulmonary function tests against disease extent on CT) and was tested in Group II. The formula for the CPI was as follows: extent of disease on CT = 91.0 − (0.65 × percent predicted diffusing capacity for carbon monoxide [DLCO]) − (0.53 × percent predicted FVC) + (0.34 × percent predicted FEV1). In group II, the CPI correlated more strongly with disease extent on CT (r2 = 0.51) than the individual pulmonary function test (DLCO the highest value, r2 = 0.38). A subanalysis demonstrated that the better fit of the CPI was ascribable to a correction of the confounding effects of emphysema. Mortality was predicted more accurately by the CPI than by a pulmonary function test in all clinical subgroups, including a separate cohort of 36 patients with histologically proven usual interstitial pneumonia (CPI, p < 0.0005; FVC, p = 0.002; PO2, p = 0.002). In conclusion, a new CPI, derived against CT and validated using split sample testing, is a more accurate prognostic determinant in usual interstitial pneumonia than an individual pulmonary function test.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recently, the Composite Physiologic Index (CPI) and the Gender-Age-Physiology (GAP) index have been most commonly applied for estimating the survival of patients with IPF [3–6].”
From Comparison of disease progression subgroups in idiopathic pulmonary fibrosis (2019) · cites this paper as [3]
In the citing paper
“CPI quantifies pulmonary function impairment due to pulmonary fibrosis, which is then correlated with the extent of fibrosis in computed tomography while excluding emphysema [3].”
From Comparison of disease progression subgroups in idiopathic pulmonary fibrosis (2019) · cites this paper as [3]
Citations
Cites
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis
BJORAKER, J. A., RYU, J. H., EDWIN, M. K., MYERS, J. L., TAZELAAR, H. D., SCHROEDER, D. R., & OFFORD, K. P. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.1.9704130 · Cited by 1,039
Predicting Survival in Idiopathic Pulmonary Fibrosis
KING, T. E., TOOZE, J. A., SCHWARZ, M. I., BROWN, K. R., & CHERNIACK, R. M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.7.2003140 · Cited by 853
Austin, J. H., Müller, N. L., Friedman, P. J., Hansell, D. M., Naidich, D. P., Remy-Jardin, M., Webb, W. R., & Zerhouni, E. A. (1996) · Radiology · doi:10.1148/radiology.200.2.8685321 · Cited by 836
Self-citationHistopathologic Variability in Usual and Nonspecific Interstitial Pneumonias
FLAHERTY, K. R., TRAVIS, W. D., COLBY, T. V., TOEWS, G. B., KAZEROONI, E. A., GROSS, B. H., JAIN, A., STRAWDERMAN, R. L., FLINT, A., LYNCH, J. P., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.9.2103074 · Cited by 665
Self-citationIdeal Alveolar Air and the Analysis of Ventilation-Perfusion Relationships in the Lungs
Riley, R. L., & Cournand, A. (1949) · Journal of Applied Physiology · doi:10.1152/jappl.1949.1.12.825 · Cited by 563
Travis, W. D., Matsui, K., Moss, J., & Ferrans, V. J. (2000) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200001000-00003 · Cited by 530
NICHOLSON, A. G., COLBY, T. V., DUBOIS, R. M., HANSELL, D. M., & WELLS, A. U. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.6.2003049 · Cited by 489
Self-citationIdiopathic Pulmonary Fibrosis: Predicting Response to Therapy and Survival
GAY, S. E., KAZEROONI, E. A., TOEWS, G. B., LYNCH, J. P., GROSS, B. H., CASCADE, P. N., SPIZARNY, D. L., FLINT, A., ANTHONY SCHORK, M., WHYTE, R. I., et al. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9703022 · Cited by 406
Determinants of survival in idiopathic pulmonary fibrosis.
Schwartz, D. A., Helmers, R. A., Galvin, J. R., Van Fossen, D. S., Frees, K. L., Dayton, C. S., Burmeister, L. F., & Hunninghake, G. W. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.2.8306044 · Cited by 340
Research works printed but not linked: 7
- 1995, Am J Respir Crit Care Med, 151, 1180
- 1997, Arthritis Rheum, 40, 1229
- 1983, Clin Respir Physiol, 19, 1
- 1994, Am J Respir Crit Care Med, 149, 450, 10.1164/ajrccm.149.2.8306044 · DOI · Paper page
- 1983, Am Rev Respir Diagn, 2, 43
- 1976, Chest, 69, 263
- 1995, Am J Respir Crit Care Med, 151, 1180
Cited by
Items 401–500 of 705
Majewski, S., Szewczyk, K., Białas, A. J., Miłkowska-Dymanowska, J., Górski, P., & Piotrowski, W. J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101590 · Cited by 15
“CPI was developed as a tool to reflect the morphologic extent of fibrosis in patients with IPF on high-resolution computed tomography (HRCT) [33].”
BackgroundMethodAchaiah, A., Fraser, E., Saunders, P., Hoyles, R. K., Benamore, R. E., & Ho, L. (2023) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2023-001801 · Cited by 15
Pulmonary Fibrosis and Diabetes Mellitus: Two coins with the same face
Mendoza‐Marí, Y., Fraix, M. P., & Agrawal, D. K. (2024) · Archives of Internal Medicine Research · doi:10.26502/aimr.0165 · Cited by 16
“In this study, circulating levels of MMP13 were directly associated to a reduction on diffusing capacity of the lungs for carbon monoxide and composite physiologic index [117], indicators for disease severity which correlates with the extent of fibrosis on radiography in patients with IPF [118].”
BackgroundAssessment of quality of life in IPF Patients: A multicenter observational study
Uzer, F., Ĉilli, A., Hanta, I., Çoşkun, F., Sevinç, C., Ursavaş, A., Leblebici, A., Yılmaz, G., Yazici, G. C., & Kamel, I. (2024) · Sarcoidosis Vasculities and Diffuse Lung Diseases · doi:10.36141/svdld.v41i3.15805 · Cited by 11
“CPI was calculated according to Wells et al.(12): CPI parameters as follows: 91.0 – (0.65 × DLCO percentage of the predicted value [% pred]) − (0.53 × FVC % pred) + (0.34 × forced expiratory volume [FEV1] % pred).”
MethodInfluentialDynapenia and Sarcopenia as Risk Factors for Mortality in Interstitial Lung Disease
Ibarra‐Fernández, A. A., Robles-Hernández, R. E., Orea‐Tejeda, A., González‐Islas, D., Jiménez‐Valentín, A., Sánchez‐Santillán, R., Arcos‐Pacheco, L. P., Gutiérrez‐Luna, E., Zurita‐Sandoval, A., Espinosa, T. P., et al. (2025) · Respirology · doi:10.1111/resp.14892 · Cited by 13
Advanced pulmonary sarcoidosis
Jeny, F., Valeyre, D., Lower, E. E., & Baughman, R. P. (2025) · Journal of Autoimmunity · doi:10.1016/j.jaut.2025.103397 · Cited by 13
Epidemiology and Prognosis of Progressive Pulmonary Fibrosis: A Literature Review
Montero, I. E., Hernández‐González, F., & Sellarés, J. (2025) · Pulmonary Therapy · doi:10.1007/s41030-025-00302-5 · Cited by 15
“Several risk factors have been sug‑ gested to influence the risk of developing PPF [22–34], including clinical features, lung func‑ tion, radiological findings, and biomarkers, with limited results for predicting outcomes in indi‑ vidual patients [35–39].”
Current State of Fibrotic Interstitial Lung Disease Imaging
Chelala, L., Brixey, A. G., Hobbs, S., Kanne, J. P., Kligerman, S. J., Lynch, D. A., & Chung, J. H. (2025) · Radiology · doi:10.1148/radiol.242531 · Cited by 13
Defining and predicting progression in non-IPF interstitial lung disease
Goos, T., Sadeleer, L. D., Yserbyt, J., Langhe, E. D., Dubbeldam, A., Verbeken, E. K., Verleden, G. M., Vermant, M., Verschakelen, J., Vos, R., et al. (2021) · Respiratory Medicine · doi:10.1016/j.rmed.2021.106626 · Cited by 14
The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness study
Cox, I. A., de Graaff, B., Ahmed, H., Campbell, J. A., Otáhal, P., Corte, T. J., Moodley, Y. P., Goh, N. S. L., Hopkins, P. M.-A., Macansh, S., et al. (2022) · The European Journal of Health Economics · doi:10.1007/s10198-022-01538-7 · Cited by 14
Self-citationDu, K., Zhu, Y., Mao, R., Qu, Y., Cui, B., Ma, Y., Zhang, X., & Chen, Z. H. (2022) · Respiratory Research · doi:10.1186/s12931-022-02276-3 · Cited by 13
Nishiyama, O., Yamazaki, R., Sano, A., Yamagata, T., Sano, H., Iwanaga, T., Higashimoto, Y., Kume, H., & Tohda, Y. (2015) · Chronic Respiratory Disease · doi:10.1177/1479972315603714 · Cited by 13
Idiopathic Pulmonary Fibrosis Among Young Patients: Challenges in Diagnosis and Management
Leuschner, G., Reiter, F., Stocker, F., Crispin, A., Kneidinger, N., Veit, T., Klenner, F., Ceelen, F., Gregor, Z., Leuchte, H. H., et al. (2018) · Lung · doi:10.1007/s00408-018-0123-9 · Cited by 13
Impact of mediastinal lymph node enlargement on the prognosis of idiopathic pulmonary fibrosis
Sin, S., Lee, K. H., Hur, J. H., Lee, S. H., Lee, Y. J., Cho, Y., Yoon, H. I., Lee, J. H., Lee, C. T., & Park, J. S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201154 · Cited by 13
Overnight desaturation in interstitial lung diseases: links to pulmonary vasculopathy and mortality
Margaritopoulos, G. A., Proklou, Α., Trachalaki, A., Bonet, D. B., Kokosi, M. A., Kouranos, V., Chua, F., George, P. M., Renzoni, E. A., Devaraj, A., et al. (2023) · ERJ Open Research · doi:10.1183/23120541.00740-2023 · Cited by 12
“The composite physiologic index (CPI) was calculated as previously described [18].”
MethodSelf-citationContribution of Peripheral Airways Dysfunction to Poor Quality of Life in Sarcoidosis
Toumpanakis, D., Karagiannis, K., Paredi, P., Bikov, A., Bonifazi, M., Lota, H., Kalsi, H. S., Minelli, C., Δικαίος, Ν., Kastis, G. A., et al. (2025) · CHEST Journal · doi:10.1016/j.chest.2025.02.036 · Cited by 12
Self-citationFibrotic Pulmonary Sarcoidosis—From Pathogenesis to Management
Łyżwa, E., Wakuliński, J., Szturmowicz, M., Tomkowski, W. Z., & Sobiecka, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14072381 · Cited by 14
“The formula is: the extent of disease on CT = 91.0 − (0.65 × percent predicted TLCO) − (0.53 × percent predicted FVC) − (0.34 x percent predicted FEV1) [181].”
InfluentialBundgaard-Nielsen, M., Johnsen, R. H., Mortensen, J., Shaker, S. B., & Nielsen, C. T. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103856 · Cited by 15
Multi-dimensional indices to stage idiopathic pulmonary fibrosis: a systematic review.
Rozanski, C., & Mura, M. (2014) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 14
Emerging potential treatments: new hope for idiopathic pulmonary fibrosis patients?
Costabel, U. (2011) · European Respiratory Review · doi:10.1183/09059180.00002011 · Cited by 12
Konishi, S., Arita, M., Ito, I., Tachibana, H., Takaiwa, T., Fukuda, Y., Watanabe, N., Tsubouchi, K., Masuda, G., Tanaka, M., et al. (2015) · Internal Medicine · doi:10.2169/internalmedicine.54.4118 · Cited by 12
Sarcoidosis. Disease progression based on radiological and functional course: Predictive factors
Casal, A., Antelo, J. S., Soto-Feijóo, R., Ferreiro, L., Rodríguez‐Núñez, N., Lama, A., Riveiro, V., Toubes, M. E., Lourido, T., Ricoy, J., et al. (2022) · Heart & Lung · doi:10.1016/j.hrtlng.2022.06.020 · Cited by 13
Pires, F. S., Mota, P. C., Melo, N. C. V., Costa, D., Jesus, J. M., Cunha, R., Guimarães, S., Souto-Moura, C., & Morais, A. (2013) · Revista Portuguesa de Pneumologia · doi:10.1016/j.rppnen.2012.06.003 · Cited by 14
Oh, J. Y., Lee, Y. S., Min, K. H., Hur, G. Y., Lee, S. Y., Kang, K. H., & Shim, J. J. (2018) · Medicine · doi:10.1097/md.0000000000011683 · Cited by 14
What parameters can be used to identify early idiopathic pulmonary fibrosis?
Mori, Y., & Kondoh, Y. (2020) · Respiratory Investigation · doi:10.1016/j.resinv.2020.10.008 · Cited by 13
Quantitative volumetric assessment of pulmonary involvement in patients with systemic sclerosis.
Çetinçakmak, M. G., Göya, C., Hamidi, C., Tekbaş, G., Abakay, Ö., Batmaz, İ., Hattapoğlu, S., Yavuz, A., & Bilici, A. (2016) · PubMed · doi:10.3978/j.issn.2223-4292.2016.02.03 · Cited by 12
“A number of techniques have been developed to measure pulmonary fibrosis, including visual inspection, and Goh, Wells and Warrick scores, which are all semi-quantitative methods (16,23,24).”
MethodHosein, K., Le, J., & Mura, M. (2016) · Lung · doi:10.1007/s00408-016-9963-3 · Cited by 12
Idiopathic Interstitial Pneumonias
King, T. E. (2006) · Humana Press eBooks · doi:10.1007/978-1-59259-963-9_21 · Cited by 12
Alveolar nitric oxide is related to periostin levels in idiopathic pulmonary fibrosis
Cameli, P., Bergantini, L., d’Alessandro, M., Vietri, L., Refini, R. M., Pieroni, M., Sestini, P., & Bargagli, E. (2020) · Minerva Medica · doi:10.23736/s0026-4806.19.06321-3 · Cited by 12
Clinical, radiological and histopathological features of patients with familial pulmonary fibrosis
Jaula, H., Mattila, L., Lappi‐Blanco, E., Salonen, J., Vähänikkilä, H., Ahvenjärvi, L., Moilanen, J. S., Kuismin, O., Harju, T. H., & Kaarteenaho, R. L. (2024) · Respiratory Research · doi:10.1186/s12931-024-02864-5 · Cited by 11
“[25].”
Li, A., Teoh, A. K. Y., Troy, L. K., Glaspole, I., WILSHER, M. L., de Boer, S., Wrobel, J. P., Moodley, Y. P., Thien, F. C. K., Gallagher, H., et al. (2024) · Thorax · doi:10.1136/thorax-2024-221813 · Cited by 12
Self-citationQiang, Y., Wang, H., Ni, Y., Wang, J., Liu, A., Yang, H., Xi, L., Ren, Y., Xie, B., Wang, S., et al. (2024) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-24-595 · Cited by 10
“Wells et al. (75) presented their composite physiologic index (CPI) as a tool to assess the morphologic extent of pulmonary fibrosis in IPF on CT scans.”
Ohde, Y., Ueda, K., Okami, J., Saito, H., Satō, T., Yatsuyanagi, E., Tsuchida, M., Mimae, T., Adachi, H., Hishida, T., et al. (2025) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-025-02120-7 · Cited by 11
“Only Kumar et al. performed an evaluation on 24 patients using the composite physiologic index (CPI) [99]: 91.0—{0.65 x %predicted DLCO}—{0.53 x %predicted FVC} + %predicted FVC + 0.34 x %predicted FEV1).”
InfluentialRadiological and Physiological Predictors of IPF Mortality
Kishaba, T., Maeda, A., Yamazato, S., Nabeya, D., Yamashiro, S., & Nagano, H. (2021) · Medicina · doi:10.3390/medicina57101121 · Cited by 11
“In the composite index of PFT, mean CPI was 59.4 ± 26.7 and mean GAP score was 4.9 ± 1.8.”
MethodInfluentialUrteaga, M. B., Ruz, J. R., & González, M. S. (2022) · Radiología · doi:10.1016/j.rx.2022.10.009 · Cited by 13
Valecchi, D., Bargagli, E., Pieroni, M., Refini, R. M., Sestini, P., Rottoli, P., & Melani, A. S. (2023) · Pulmonary Therapy · doi:10.1007/s41030-023-00215-1 · Cited by 13
Chest CT features and functional correlates of COVID-19 at 3 months and 12 months follow-up
Kumar, K., Ratnakumar, R., Collin, S. M., Berrocal-Almanza, L. C., Ricci, P., Al-Zubaidy, M., Coker, R. K., Coleman, M., Elkin, S., Mallia, P., et al. (2023) · Clinical Medicine · doi:10.7861/clinmed.2023-0059 · Cited by 12
Sugino, K., Shimizu, H., Nakamura, Y., Isshiki, T., Matsumoto, K., & Homma, S. A. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.01.56 · Cited by 11
Harari, S. A., Caminati, A., Confalonieri, M., Poletti, V. E., Vancheri, C., Pesci, A., Rogliani, P., Luppi, F., Agostini, C., Rottoli, P., et al. (2019) · The Clinical Respiratory Journal · doi:10.1111/crj.12999 · Cited by 12
Hosein, K., Sergiacomi, G., Zompatori, M., & Mura, M. (2019) · Lung · doi:10.1007/s00408-019-00295-4 · Cited by 11
Fukuda, C. Y., Soares, M. R., & Pereira, C. A. D. C. (2020) · Medicine · doi:10.1097/md.0000000000020739 · Cited by 11
“Similarly, a worse prognosis has been observed for males in some studies([4,7,9]) but not in others.([5,6,8,14,20]) General mortality was considered in a majority of studies on survival with IPF, and most deaths (approximately 80%) in IPF result from progression of lung fibrosis rather than from other causes.”
BackgroundMethodResultInfluentialEvolving Concepts in the Early and Accurate Diagnosis of Idiopathic Pulmonary Fibrosis
du Bois, R. M. (2006) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2005.08.001 · Cited by 11
Comparing effectiveness of prognostic tests in idiopathic pulmonary fibrosis
Moua, T., Lee, A. S., & Ryu, J. H. (2019) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2019.1656069 · Cited by 10
Oxygen saturation recovery after 6-minute walk test in patients with idiopathic pulmonary fibrosis
Oğuz, M. S., Bingöl, Z., Pıhtılı, A., Özer, P. K., Arslan, M. S., Kılıçaslan, Z., Bilge, A. K., Kıyan, E., & Okumuş, G. (2024) · BMC Pulmonary Medicine · doi:10.1186/s12890-024-03188-2 · Cited by 10
Swaminathan, A. C., Weber, J. M., Todd, J. L., Palmer, S. M., Neely, M. L., Whelan, T. P. M., Kim, G. H. J., Leonard, T. B., & Goldin, J. G. (2025) · Respiratory Research · doi:10.1186/s12931-025-03136-6 · Cited by 11
“The measures of disease severity were FVC % predicted, DLco % predicted, GAP stage (I, II, III) [35], composite physiologic index (CPI) [36] and supplemental oxygen use (at rest, with exertion, none).”
Survival of patients with asbestosis can be assessed by risk-predicting models
Keskitalo, E., Salonen, J., Vähänikkilä, H., & Kaarteenaho, R. L. (2021) · Occupational and Environmental Medicine · doi:10.1136/oemed-2020-106819 · Cited by 11
Serum Krebs von den Lungen-6: promising biomarker to differentiate CPFE from IPF.
Demirdöğen, E., Dilektaşlı, A. G., Öztürk, N. A. A., Yeşilbursa, D., Budak, F., Çoşkun, F., Öztürk, A., Ursavaş, A., Özkaya, G., Karadağ, M., et al. (2022) · Sarcoidosis vasculitis and diffuse lung diseases · doi:10.36141/svdld.v39i4.11344 · Cited by 10
Su, N., Hou, F. F., Zheng, W., Wu, Z., & Linning, E. (2023) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0000000000001484 · Cited by 10
Idiopathic pulmonary fibrosis: current and future directions
Soo, E., Adamali, H. I., & Edey, A. (2017) · Clinical Radiology · doi:10.1016/j.crad.2016.12.014 · Cited by 11
Personalized medicine in interstitial lung diseases
Spagnolo, P., Oldham, J. M., Jones, M. G., & Lee, J. S. (2017) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000370 · Cited by 11
Ono, M., Kobayashi, S., Hanagama, M., Ishida, M., Sato, H., Makiguchi, T., & Yanai, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239764 · Cited by 10
Defining prognosis in sarcoidosis
Lopes, M. C., Amadeu, T. P., Alves, M. R., da Costa, C. H., Silva, B. R. A., Rodrigues, L. S., Bessa, E. J. C., Bruno, L. P., Lopes, A. J., & Rufino, R. (2020) · Medicine · doi:10.1097/md.0000000000023100 · Cited by 12
“Walsh et al([42]) constructed an algorithm combining pulmonary function tests using the composite physiologic index (CPI) with computed tomography evaluation of the presence and extent of fibrosis, and the ratio of the main pulmonary artery diameter to the ascending aorta diameter, to categorize cases as good or poor…”
MethodCottin, V., Bonniaud, P., Cadranel, J. L., Crestani, B., Jouneau, S., Marchand-Adam, S., Nunès, H., Wémeau-Stervinou, L., Bergot, E., Blanchard, É., et al. (2022) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2022.01.014 · Cited by 14
Portillo, K., Pérez-Rodas, N., García-Olivé, I., Guasch-Arriaga, I., Centeno, C., Serra, P., Becker-Lejuez, C., Santos, J. S., Andreo, F., & Manzano, J. R. (2017) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2017.04.006 · Cited by 10
“34×percentage predicted forced expiratory volume in 1 second [FEV1]).(31)”
Ohno, S., Nakazawa, S., Kobayashi, A., Bando, M., & Sugiyama, Y. (2005) · Internal Medicine · doi:10.2169/internalmedicine.44.196 · Cited by 10
Nathan, S. D. (2005) · CHEST Journal · doi:10.1378/chest.128.5_suppl_1.533s · Cited by 10
Iwakawa, J., Matsuyama, W., Kubota, S., Mitsuyama, H., Suetsugu, T., Watanabe, M., Higashimoto, I., Osame, M., & Arimura, K. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2006.02.006 · Cited by 10
Sverzellati, N., & Brillet, P. (2017) · European Respiratory Journal · doi:10.1183/13993003.02144-2016 · Cited by 10
Towards a refined definition of combined pulmonary fibrosis and emphysema
Swigris, J. J. (2018) · Respirology · doi:10.1111/resp.13426 · Cited by 10
Comorbidities’ Effect on IPF: Pathogenesis and Management
Salotti, A., Chianese, M. I., Romallo, A., Nes, A. D., Angoni, D., Galantino, A., Chernovsky, M., Mondini, L., Salton, F., Confalonieri, P., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13061362 · Cited by 9
“Given a consistent level of fibrosis, emphysema appears to exert an additive negative effect on outcomes [37,38,40].”
Clinical Trials in IPF: What Are the Best Endpoints?
Spagnolo, P., Cocconcelli, E., & Cottin, V. (2018) · Respiratory medicine · doi:10.1007/978-3-319-99975-3_19 · Cited by 9
Heme Oxygenase-1 in Patients With Interstitial Lung Disease: A Review of the Clinical Evidence
Hara, Y., Nakashima, K., Nagasawa, R., Murohashi, K., Tagami, Y., Aoki, A., Okudela, K., & Kaneko, T. (2021) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2021.02.009 · Cited by 9
Deep learning-based prognostication in idiopathic pulmonary fibrosis using chest radiographs
Lee, T., Ahn, S. Y., Kim, J., Park, J. S., Kwon, B. S., Choi, S. M., Goo, J. M., Park, C. M., & Nam, J. G. (2023) · European Radiology · doi:10.1007/s00330-023-10501-w · Cited by 9
“Previous studies [6, 7] have proposed various prediction models integrating multiple clinical variables.”
Guler, S. A., Wohlfarth, E., Berezowska, S., Geiser, T., Ebner, L., & Funke-Chambour, M. (2021) · Respiratory Research · doi:10.1186/s12931-021-01727-7 · Cited by 9
“We calculated the Composite Physiologic Index (CPI), which was developed to predict radiological extent of fibrosis by aggregating forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), and diffusing capacity of the lung for carbon monoxide (DLCO).[13] Serum IgG against specific antigens were measured in…”
MethodJee, A. S., Parker, M. J. S., McGill, N. W., Bleasel, J. F., Webster, S. E., Troy, L. K., & Corte, T. J. (2021) · ERJ Open Research · doi:10.1183/23120541.00416-2021 · Cited by 10
Models of disease behavior in idiopathic pulmonary fibrosis
Johannson, K. A., Ley, B., & Collard, H. R. (2015) · BMC Medicine · doi:10.1186/s12916-015-0403-7 · Cited by 11
“The Composite Physiologic Index was similarly developed, incorporating three lung function parameters to predict mortality and accounting for the confounding effects of concomitant emphysema in IPF patients [5], a limitation of prior models.”
MethodBurgess, A., Goon, K., Brannan, J. D., Attia, J. R., Palazzi, K. L., Oldmeadow, C. J., Corte, T. J., Glaspole, I., Goh, N. S. L., Keir, G. J., et al. (2019) · Respirology · doi:10.1111/resp.13540 · Cited by 9
Self-citationKing, T. E. (2004) · PubMed · Cited by 10
Right vocal cord paralysis and mediastinal lymphadenopathy
Boyd, M. B., Malaisamy, S., Ie, S., & Rubio, E. (2010) · Thorax · doi:10.1136/thx.2010.140012 · Cited by 9
Is big beautiful? The continuing story of ADAM33 and asthma
Holgate, S. T., & Holloway, J. W. (2005) · Thorax · doi:10.1136/thx.2004.031385 · Cited by 10
Broad Therapeutic Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis
Wells, A. U., & Rosas, I. O. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201510-2052ed · Cited by 9
“simply a poor measure of disease severity when compared with diffusing capacity of the lung for carbon monoxide (DLCO) levels or composite indices (8, 9).”
BackgroundSelf-citation(2024) · Springer eBooks · doi:10.1007/978-981-99-9283-6_1305 · Cited by 9
Gogali, A., Gkrepi, G., Kyriakopoulos, C., Tatsis, K., Κatsoulis, Κ., Tselepi, C., & Κostikas, Κ. (2024) · Diagnostics · doi:10.3390/diagnostics14242873 · Cited by 8
“We also calculated the composite physiologic index (CPI), an index that reflects the extent of pulmonary fibrosis better than individual pulmonary function tests and is associated with prognosis including mortality [9].”
Treatable traits in interstitial lung disease: a narrative review
Harrison, M., Lawler, C., Lake, F., Navaratnam, V. V., Fermoyle, C. C., Moodley, Y. P., & Corte, T. J. (2025) · Therapeutic Advances in Respiratory Disease · doi:10.1177/17534666251335774 · Cited by 8
The diagnosis of idiopathic pulmonary fibrosis and its complications
Maher, T. M. (2008) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530050802549484 · Cited by 8
“As such, the CPI correlates well with disease extent on CT and has been shown to be a better predictor of survival than any of its individual components [29,61] .”
Image biomarkers for quantitative analysis of idiopathic interstitial pneumonia
Fetita, C. I., Kim, Y.-W., Tarando, S. R., & Brillet, P. (2019) · SPIE Medical Imaging: Computer-Aided Diagnosis · doi:10.1117/12.2511847 · Cited by 8
Yamazaki, R., Nishiyama, O., Yoshikawa, K., Tohda, Y., & Matsumoto, H. (2022) · Respiratory Medicine · doi:10.1016/j.rmed.2022.106933 · Cited by 8
Zhang, X., Ren, Y., Xie, B., Ye, Q., Ban, C., Zhang, S., Zhu, M., Liu, Y., Wang, S., Geng, J., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.955125 · Cited by 9
Lopes, A. J., Capone, D., Mogami, R., da Cunha, D. L., de Melo, P. L., & Jansen, J. M. (2007) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132007000600010 · Cited by 8
IC4: a new combined predictive index of mortality in idiopathic pulmonary fibrosis
Zinellu, A., Collu, C., Zinellu, E., Ahmad, K., Nasser, M., Traclet, J., Sotgiu, E., Mellino, S., Mangoni, A. A., Carru, C., et al. (2022) · Panminerva Medica · doi:10.23736/s0031-0808.21.04144-6 · Cited by 8
Tanabe, N., Kaji, S., Satô, S., Yokoyama, T., Oguma, T., Tanizawa, K., Handa, T., Sakajo, T., & Hirai, T. (2021) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00150.2021 · Cited by 11
“The composite physiological index (CPI), which has been used as a major index to estimate fi brosis, was calculated using the following equation: 91.0 (21).”
MethodResultInfluentialSmoking-related interstitial lung disease
Cerri, S., Spagnolo, P., Luppi, F., & Richeldi, L. (2011) · European Respiratory Society eBooks · doi:10.1183/1025448x.10008710 · Cited by 9
Izumi, T., Shigematsu, M., Nagao, T., Mishima, M., Kitaichi, M., Hamada, K., Nagai, S., Tanaka, S., & Handa, T. (2007) · Cited by 8
Lee, G., Kim, K. U., Lee, J. W., Suh, Y. J., & Jeong, Y. J. (2016) · Acta Radiologica · doi:10.1177/0284185116664227 · Cited by 8
“CPI is an index based on pulmonary function test results which has been reported to be correlated with the extent of pulmonary fibrosis at CT while excluding the effect attributable from emphysema (14).”
BackgroundGeorge, P. M., & Wells, A. U. (2018) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2018.1427064 · Cited by 9
Self-citationPulmonary Hypertension in Interstitial Lung Disease
Carbone, R. G., Monselise, A., & Bottino, G. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-074-8_2 · Cited by 8
“[69] developed a composite physiologic index, where patients with IPF were evaluated with HRCT and pulmonary functional tests (i.”
MethodHu, P., Chen, C.-K., Hsiao, Y., Weng, C., Lee, Y., Su, K., Feng, J., Chou, K., Perng, D., & Ko, H. (2024) · Respirology · doi:10.1111/resp.14811 · Cited by 7
Salvador-Corres, I., Quirant‐Sánchez, B., Teniente‐Serra, A., Centeno, C., Moreno, A., Rodríguez-Pons, L., Serra, P., García-Núñez, M., Martínez-Cáceres, E. M., Rosell, A., et al. (2021) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2021.03.009 · Cited by 7
Li, C., Wang, Y., Liu, Q., Zhang, H., Xu, F., Gao, Z., Wang, X., Tao, G., Chen, Y., Rong, W., et al. (2022) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2022.2093717 · Cited by 7
“CPI was used to quantitatively describe the overall lung function state of the subject [13],”
MethodTransferability of radiomic signatures from experimental to human interstitial lung disease
Gabryś, H. S., Gote-Schniering, J., Brunner, M., Bogowicz, M., Blüthgen, C., Frauenfelder, T., Gückenberger, M., Maurer, B., & Tanadini‐Lang, S. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.988927 · Cited by 7
Pulmonary Function Tests in Idiopathic Pulmonary Fibrosis
Wells, A. U., & Ward, S. P. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-682-5_6 · Cited by 7
Self-citationTobin, M. J. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2312006 · Cited by 7
Roeser, A., Brillet, P., Ba, S. T., Caux, F. A., Dhôte, R., Nunès, H., & Uzunhan, Y. (2025) · Respiratory Research · doi:10.1186/s12931-025-03375-7 · Cited by 6
“Composite physiological index (CPI) was calculated according to Wells et al. [21].”
Pan, D., Wang, Q., Yan, B., & Su, X. (2024) · Journal of Health Population and Nutrition · doi:10.1186/s41043-024-00620-5 · Cited by 7
Kitaguchi, Y., Fujimoto, K., Droma, Y., Yasuo, M., Wada, Y., Ueno, F., Kinjo, T., Kawakami, S., Fukushima, K., & Hanaoka, M. (2021) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0000000000001182 · Cited by 6
Perotin, J., Gierski, F., Bolko, L., Dury, S., Barrière, S., Launois, C., Dewolf, M., Chouabe, S., Bongrain, É., Picard, D., et al. (2022) · Respiratory Research · doi:10.1186/s12931-022-02111-9 · Cited by 6
Tang, C., Wang, L., Chen, Z., Yang, J. P., Gao, H., Guan, C., Gu, Q., He, S., Yang, F., Chen, S., et al. (2023) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s438044 · Cited by 6
“22 Here, our study showed a greater degree of decline in CPI in the HW group.”
BackgroundBiomarkers in Idiopathic Pulmonary Fibrosis
Sood, S., Russell, T. D., & Shifren, A. (2018) · Respiratory medicine · doi:10.1007/978-3-319-99975-3_10 · Cited by 7
The impact of idiopathic pulmonary fibrosis on health state utility values: evidence from Australia
Cox, I. A., de Graaff, B., Ahmed, H., Campbell, J. A., Otáhal, P., Corte, T. J., Glaspole, I., Moodley, Y. P., Goh, N. S. L., Macansh, S., et al. (2021) · Quality of Life Research · doi:10.1007/s11136-021-02879-1 · Cited by 6
Self-citationA formula for predicting emphysema extent in combined idiopathic pulmonary fibrosis and emphysema
Wells, A. U., Jacob, J., Sverzellati, N., Cross, G., Barnett, J. L., Lauretis, A. D., Antoniou, K. M., Weycker, D. A., Atwood, M., Kirchgaessler, K.-U., et al. (2024) · Respiratory Research · doi:10.1186/s12931-023-02589-x · Cited by 6
“A similar methodology to that used to develop the CPFE Index was used to develop the CPI, a formula designed to predict fibrosis extent independently of emphysema extent in patients with IPF [22].”
MethodInfluentialSelf-citation
Metadata
- Authors
- Wells, A. U., Desai, S. R., Rubens, M. B., Goh, N. S. L., Cramer, D., Nicholson, A. G., Colby, T. V., du Bois, R. M., & Hansell, D. M.
- Affiliations
- Mayo Clinic (US)
- Department of Radiology and Department of Physiology Royal Brompton Hospital, Interstitial Lung Disease Unit; Department of Radiology, King's College Hospital, London, United Kingdom; and Department of Pathology, Mayo Clinic, Scottsdale, Arizona
- ORCID
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-04-01
- Volume
- 167
- Issue
- 7
- Pages
- 962-969
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W3022958008
- Cited by
- 686
- References
- 32
- Citations by year
- 2026: 18 · 2025: 31 · 2024: 28 · 2023: 39 · 2022: 37 · 2021: 48 · 2020: 42 · 2019: 40 · 2018: 40 · 2017: 52 · 2016: 47 · 2015: 42 · 2014: 27 · 2013: 38 · 2012: 22
- FWCI
- 12.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- idiopathic pulmonary fibrosis, usual interstitial pneumonia, composite physiologic index, pulmonary function tests, diffusing capacity for carbon monoxide, mortality prediction, prognostic score
- MeSH terms
- Aged, Biopsy, Carbon Monoxide, Female, Follow-Up Studies, Forced Expiratory Volume, Humans, Lung, Male, Middle Aged, Monitoring, Physiologic, Predictive Value of Tests, Prognosis, Pulmonary Diffusing Capacity, Pulmonary Emphysema, Pulmonary Fibrosis, Statistics as Topic, Tomography, X-Ray Computed, Total Lung Capacity, Vital Capacity, Survival Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.